🇺🇸 FDA
Company

Xeris

Xeris Biopharma Holdings

XERS biotech USA

Quick answer

Xeris is a biotech company (XERS) headquartered in CHICAGO, IL, USA with 16 tracked pipeline programs.

Pipeline (16)

project

G-Pen

Insulin Hypoglycemia

Phase 3 · small_molecule · completed

1 trials project

G-Pen (glucagon injection)

Hypoglycemia

Phase 3 · small_molecule · completed

1 trials project

Glucagon

Diabetes Mellitus, Type 1

Phase 3 · small_molecule · completed

1 trials project

G-Pen Mini™ (glucagon injection)

Hypoglycemia

Phase 2 · small_molecule · completed

1 trials project

G-Pen Mini™ (glucagon injection)

Diabetes Mellitus, Type 1

Phase 2 · small_molecule · completed

2 trials project

G-Pen(TM) 1 mg

Hypoglycemia

Phase 2 · small_molecule · completed

1 trials project

G-Pump™ (glucagon infusion)

Hypoglycemia

Phase 2 · small_molecule · completed

1 trials project

Glucagon

Hypoglycemia

Phase 2 · small_molecule · completed

1 trials project

Glucagon

Congenital Hyperinsulinism

Phase 2 · small_molecule · completed

1 trials project

Glucagon RTU

Hyperinsulinemic Hypoglycemia

Phase 2 · small_molecule · completed

1 trials project

Glucagon RTU Injection With Insulin Pump Reduction

Hypoglycemia

Phase 2 · small_molecule · completed

1 trials project

Novo Nordisk GlucaGen®

Hypoglycemia

Phase 2 · small_molecule · completed

1 trials project

PRAM9

Diabetes Mellitus, Type 1

Phase 2 · small_molecule · completed

1 trials project

glucagon

Post-bariatric Hypoglycemia

Phase 2 · small_molecule · completed

1 trials project

levothyroxine sodium

Hypothyroidism

Phase 2 · small_molecule · completed

1 trials project

XeriSol glucagon

Type1diabetes

Phase 1 · small_molecule · completed

1 trials

Drugs (1)

drug

dichlorphenamide

ORMALVI

Patents (8)

patent

US 12377096

Methods of treating disease with levoketoconazole

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11964003

Stable sustained release therapeutic compositions in aprotic polar solvents and

Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11957736

Stable therapeutic compositions in aprotic polar solvents and methods of manufac

Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11833157

Precipitation resistant small molecule drug formulations

Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11590205

Methods for producing stable therapeutic glucagon formulations in aprotic polar

Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11576951

Stable therapeutic compositions in aprotic polar solvents and methods of manufac

Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11446310

Stable formulations for parenteral injection of small molecule drugs

Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11129940

Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of

Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)